Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2003

01-12-2003

Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model

Authors: Edward L. Nelson, Darue Prieto, Terri G. Alexander, Peter Pushko, Loreen A. Lofts, Jonathan O. Rayner, Kurt I. Kamrud, Bolyn Fralish, Jonathan F. Smith

Published in: Breast Cancer Research and Treatment | Issue 3/2003

Login to get access
Metadata
Title
Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model
Authors
Edward L. Nelson
Darue Prieto
Terri G. Alexander
Peter Pushko
Loreen A. Lofts
Jonathan O. Rayner
Kurt I. Kamrud
Bolyn Fralish
Jonathan F. Smith
Publication date
01-12-2003
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2003
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/B:BREA.0000004373.09678.bb

Other articles of this Issue 3/2003

Breast Cancer Research and Treatment 3/2003 Go to the issue

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine